News Focus
News Focus
icon url

dirtbag james

01/26/12 2:24 AM

#737 RE: doogdilinger #735

For 2013, he predicts earnings per share of 30 cents.12-month price target of $5.25,

http://biotuesdays.com/2012/01/25/roth-starts-intellipharmaceutics-at-buy/
icon url

doogdilinger

02/17/12 8:52 AM

#822 RE: doogdilinger #735

Intellipharmaceutics to Present at Upcoming Cowen Healthcare and Roth Conferences
PrintAlert
Intellipharmaceutics International Inc. (MM) (NASDAQ:IPCI)
Intraday Stock Chart
Today : Friday 17 February 2012

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that management will be presenting at two upcoming investor conferences.

Dr. Isa Odidi, CEO, will present a Company overview at the Cowen Healthcare Conference in Boston, MA at 3:30 p.m. EST on Monday, March 5, 2012.

Shameze Rampertab, Vice President Finance and Chief Financial Officer, will present a Company overview at the 24th annual Roth Conference in Laguna Niguel, CA at 9:00am PST on Wednesday, March 14, 2012.

The presentations will be webcast live and may be accessed through the Investor Relations' Events and Presentations section on Intellipharmaceutics' website at www.intellipharmaceutics.com. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. An archived replay will also be available for 90 days following the live presentation.